By its Decision no 845/2024 adopted on the 19th of April 2024, the Hellenic Competition Commission (HCC), in Plenary, unanimously approved, pursuant to Article 8 (3) of Greek Law 3959/2011, the notified concentration concerning the acquisition by “HELLENIC HEALTHCARE HOLDING 3 (CYPRUS) LIMITED” (HH3) and “University of Nicosia” of joint control over (a) “University of Nicosia Greece Branch Medical Limited” and (b) “VANES Limited”. 

HH3 is based in Cyprus and is indirectly controlled by the investment fund CVC. CVC is active, inter alia, in the health, e-commerce, food and insurance sectors.

University of Nicosia is based in Cyprus and is controlled by “EDEX Educational Excellence Corporation Ltd” (EDEX). The University of Nicosia provides university education services in Cyprus as well as online, while EDEX, through its subsidiaries, provides professional education and training services in Greece.

“University of Nicosia Greece Branch Medical Limited” is under establishment and
will establish and operate a Medical School in Athens, under the provisions of Law 5094/2024, after receiving the necessary administrative permits from the competent bodies.

“VANES Limited” is active in the real estate market.

The HCC, by its decision, concluded that the concentration is not expected to affect the competitive conditions in any of the relevant markets concerned, as no anticompetitive horizontal, vertical or spillover effects were detected. Therefore, whereas the concentration falls within the scope of article 6(1) of Greek Law 3959/2011, the HCC, by its decision, concluded that it does not raise serious concerns as to its compatibility with competition rules in the relevant markets it concerns.